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Background: The question of when to perform coronary revascularization in patients with non-ST elevation myocardial infarction (NSTEMI) has 
been controversial. We hypothesized that the best timing of revascularization for NSTEMI may be different between in the elderly patients and the 
young patients. 
Method: We retrospectively compared the 30-day mortality of the NSTEMI patients who underwent revascularization (PCI or CABG) < 24 hours after 
admission to that of those who underwent revascularization ≥ 24 hours after admission. We divided the population into two groups according to 
their age (< 75 yo or ≥ 75 yo). We used the multi-center database of the patients brought to the coronary care unit of the 60 hopitals in Tokyo, Japan 
since January 2007 to December 2009. 
Results: In the young patients (n = 535, mean age; 61.9 ± 9.0 yo [33 yo to 74 yo]), the 30-day mortality of those who underwent revascularization 
< 24 hours after admission (4.9%, n = 288, mean age; 61.4 ± 9.1 yo) was not significantly different from that of those who underwent 
revascularization ≥ 24 hours after admission (2.4%, n = 247, mean age; 62.4 ± 8.8 yo, P = 0.1399 by Student’s t-test). But in the elderly patients 
(n = 340, mean age; 82.0 ± 5.2 yo [75 yo to 100 yo]), the 30-day mortality of those who underwent revascularization < 24 hours after admission 
(6.8%, n = 146, mean age; 80.8 ± 4.4 yo) was significantly lower than that in those who underwent revascularization ≥ 24 hours after admission 
(16.0%, n = 194, mean age; 82.8 ± 5.6 yo, P = 0.0104). The rate of comorbidities such as heart failure, or bleeding was not significantly different 
between in the early revascularization group and in the late revascularization group. The rate of procedure-related complications including death, 
myocardial infarction, stroke, and major bleeding were modestly higher in the elderly patients than in the young patients (1.8 % vs 0.7 %, P = 0.168), 
but was not affected by the timing of the revascularization. 
Conclusion: Early revascularization significantly reduced the 30-day mortality compared to the delayed revascularization in the elderly NSTEMI 
patients. Elderly NSTEMI patients receive more benefit from early revascularization than young patients.
